Showing 14 of 34 recruiting trials for “choroidal-osteoma”
PHP in Combination With IPI1/NIVO3 Compared to IPI3/NIVO1 Only in Patients With Uveal Melanoma Liver Metastases
👨⚕️ Roger Olofsson Bagge, Professor, Sahlgrenska Universitetssjukhuset📍 6 sites📅 Started Jun 2024View details ↗
A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma
RecruitingNCT05733728 ↗
Retrospective Register for Uveal Melanoma
Olaparib in Combination With Pembrolizumab for Advanced Uveal Melanoma
Adjuvant Melatonin for Uveal Melanoma
👨⚕️ Gustav Stålhammar, MD PhD, St. Erik Eye Hospital and Karolinska Institutet📍 1 site📅 Started Oct 2022View details ↗
Targeted Alpha Particle Radiotherapy for Metastatic Uveal Melanoma
A Study of Concurrent Stereotactic Body Radiotherapy With Opdualag in Metastatic Uveal Melanoma
👨⚕️ David R Minor, MD, California Pacific Med Center Research Inst.📍 1 site📅 Started Sep 2021View details ↗
Melphalan Chemoreduction for Ocular Melanoma
Safety and Preliminary Efficacy of MBS8(1V270) in Cancer Patients With Advanced Solid Tumours
👨⚕️ Kristoffer S Rohrberg, MD PhD, University Hospital of Denmark, Department of Oncology📍 5 sites📅 Started Apr 2021View details ↗
MAGE-C2 TCR T Cell Trial to Treat Melanoma and Head and Neck Cancer
Follow-up of Patients With Uveal Melanoma Adapted to the Risk of Relapse (SALOME)
RecruitingNCT03941379 ↗
A Registry of Subjects With Primary Indeterminate Lesions or Choroidal Melanoma
RecruitingNCT05377957 ↗
Prospective Registration Of Patient Data and Quality of Life in Eye Melanoma Patients
👨⚕️ Nanda Horeweg, Md PhD, Leiden University Medical Center📍 1 site📅 Started Mar 2019View details ↗
RecruitingNCT01438658 ↗
Assessing the Clinical Effectiveness of Serum Biomarkers in the Diagnosis of Metastatic Uveal Melanoma
← PreviousPage 2 of 2
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →